Biomechanics Company Receives a BioNest Grant from Greater Winston-Salem Inc. to Support Continued Growth Elemance, a biomechanics engineering company that was launched out of Wake Forest University Health Sciences, is expanding into a larger footprint within the Innovation Quarter to accommodate planned growth. The project is expected to generate $200,000 of investment and create five… Read More »
Category: Economic Development
Elemance Announces Expansion in the Innovation Quarter
Life Sciences Company GeisterBio Expands Operations in Winston-Salem
Company receives grants from the NSF Regenerative Medicine Engine in North Carolina and Greater Winston-Salem Inc. BioNest Fund GeisterBio, Inc., a U.S. life sciences company founded by Austrian entrepreneur Noah Geister, is expanding its operations in Winston-Salem. Geister founded the company here after visiting the region in March 2025 and experiencing its regenerative medicine research… Read More »
Charter Medical Receives BioNest Grant
Funding Supports R&D Capabilities for Advanced Therapy Manufacturing Charter Medical, a leading developer and manufacturer of single-use solutions, has been awarded a grant from the BioNest Fund to expand its research and development operations in Winston-Salem’s Innovation Quarter (iQ). The grant enables Charter Medical to perform a phased buildout of the laboratory space the company… Read More »
Local Company Developing Nex-Gen Chemotherapy Receives BioNest Grant for Next Phase of Growth
Deep Creek Pharma Pursuing FDA Approval for Revolutionary Treatment A pharmaceutical development startup born from local cancer research is getting a boost in its next phase of growth through Greater Winston-Salem Inc.’s BioNest Grant. Deep Creek Pharma is developing a next-generation chemotherapy that could replace the current standard of care for many solid tumor indications.… Read More »
Winston-Salem Partner’s Roundtable Fund Announces New Investments
Local angel fund has made new investments in three early-stage companies The Winston-Salem Partners Roundtable (WSPR) Fund is proud to support the growth of three local startups with new rounds of funding for the following companies: KeraVet Bio is the maker of KeraVet® Gel, a revolutionary new prescription hydrogel developed with the human-animal bond… Read More »
Korean Biopharmaceutical Company, CorestemChemon, Selects Winston-Salem’s Wake Forest Institute for Regenerative Medicine (WFIRM) for US Base of Operations
Company Receives BioNest Grant to Support Entry into US Market CorestemChemon, a biopharmaceutical company headquartered in South Korea, has selected Winston-Salem as the location for its U.S. base of operations. The company will be located within the Regenerative Medicine (RegenMed) Engine’s Innovation Accelerator, based in the Innovation Quarter. With about 350 employees worldwide, CorestemChemon is… Read More »